ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P26
Within normal range
vs 2Y Ago
-1.9x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -82.83% |
| Q3 2025 | -45.01% |
| Q2 2025 | 354.96% |
| Q1 2025 | 13.19% |
| Q4 2024 | 74.63% |
| Q3 2024 | -40.90% |
| Q2 2024 | -5.28% |
| Q1 2024 | -65.75% |
| Q4 2023 | 44.70% |
| Q3 2023 | 100.12% |
| Q2 2023 | -27.64% |
| Q1 2023 | 352.86% |
| Q4 2022 | -21.82% |
| Q3 2022 | 51.65% |
| Q2 2022 | 39.37% |
| Q1 2022 | -68.25% |
| Q4 2021 | -109.74% |
| Q3 2021 | 72.43% |
| Q2 2021 | -208.92% |
| Q1 2021 | 354.61% |
| Q4 2020 | -5.46% |
| Q3 2020 | -141.17% |
| Q2 2020 | 132.29% |
| Q1 2020 | -1901.16% |
| Q4 2019 | -84.39% |
| Q3 2019 | 2426.84% |
| Q2 2019 | 113.11% |
| Q1 2019 | -122.86% |
| Q4 2018 | 277.50% |
| Q3 2018 | 197.13% |
| Q2 2018 | -88.68% |
| Q1 2018 | 160.19% |
| Q4 2017 | -334.94% |
| Q3 2017 | 734.13% |
| Q2 2017 | 95.05% |
| Q1 2017 | -535.47% |
| Q4 2016 | 213960.00% |
| Q3 2016 | 99.99% |
| Q2 2016 | 22.64% |
| Q1 2016 | -2173.45% |